Healthy Living BEYOND Weight Study
Part of paid clinical trials in Dallas, Texas.
- Sponsor
- American Heart Association
- Study ID
- NCT07075341
- Status
- Recruiting
Conditions
- Overweight or Obesity
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- None - Observational study — OTHERNone - Observational study
Study Details
The Healthy Living BEYOND Weight Study is an observational research study of participants living with overweight and obesity. The principal objectives for this project will be to answer fundamental unanswered questions regarding patient experiences and outcomes related to overweight and obesity, and to assess the real-world effectiveness of different weight management strategies, within contemporary and diverse populations. To accomplish this, the Study Team for this project will leverage their expertise in the science of obesity and cardiometabolic health; epidemiology, cohort and registry studies; implementation science; cardiovascular prevention and management; and disparities and community-based research to lead the development of an innovative cohort of people living with overweight or obesity with two key components: 1. patient-report data elements, obtained through surveys; 2. linkage to EHR records providing data regarding clinical encounters. The cohort will be inclusive, comprehensive, and constructed with scientific rigor as well as high internal and external validity. An overall objective is for the Healthy Living BEYOND Weight Study is to serve as an enduring resource for researchers studying the health consequences of obesity and evaluating the impact of weight management strategies.
Key Dates
- Start date
- Jun 30, 2025
- Status verified
- Aug 2025
- Primary completion
- Dec 31, 2060
- Completion
- Dec 31, 2060
Study Design
- Enrollment
- 1,000,000 participants (estimated)
Arms
- Arm: Direct-to-Participant GroupObservational
Primary Outcome Measure
Answer fundamental unanswered questions regarding patient experiences and outcomes related to overweight and obesity. [ Time Frame: From enrollment to at least 10 years post enrollment, continuous follow up ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| American Heart Association | Dallas | Texas | 75231 |
Find similar trials in Dallas, TX
Related Studies
- A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)PHASE4 · Recruiting · Eli Lilly and Company · Phoenix, Arizona
- A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)PHASE4 · Recruiting · Eli Lilly and Company · Avondale, Arizona
- A Study of LY4064912 in Healthy Participants and With Overweight or ObesityPHASE1 · Recruiting · Eli Lilly and Company · Los Alamitos, California
- Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or OverweightPHASE3 · Recruiting · Eli Lilly and Company · Mobile, Alabama